- Home
- WIW vs ABSI Comparison
WIW vs ABSI Comparison
Compare WIW & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$2.70
Company Overview
Basic Information| Metric | WIW | ABSI |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.8M | 577.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WIW | ABSI |
|---|---|---|
| Price | $8.64 | $2.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | 229.9K | ★ 3.7M |
| Earning Date | 01-01-0001 | 03-17-2026 |
| Dividend Yield | ★ 11.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,815,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $313.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.01 | $2.01 |
| 52 Week High | $9.37 | $6.33 |
Technical Indicators
Market Signals| Indicator | WIW | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | N/A |
| Support Level | $8.58 | N/A |
| Resistance Level | $8.63 | N/A |
| Average True Range (ATR) | 0.03 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 95.46 | 0.00 |
Price Performance
Historical Comparison WIW
ABSI
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.